BofA analyst Geoff Meacham lowered the firm’s price target on Genfit to $4 from $5 and keeps an Underperform rating on the shares.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly